Inventor
BRUEGGEMEIER ULF
DE19 patents
⚠️ This page may combine multiple inventors who share the name “BRUEGGEMEIER ULF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
9 patentsUS6420396B1Jul 16, 2002
Biphenyl and biphenyl-analogous compounds as integrin antagonists
BAYER AG59 citations96
US6677360B2Jan 13, 2004
Biphenyl and biphenyl-analogous compounds as integrin antagonists
BAYER AG29 citations92
US6291503B1Sep 18, 2001
β-phenylalanine derivatives as integrin antagonists
BAYER AG25 citations92
US5723031AMar 3, 1998
Method for the analytical separation of viruses
BAYER AG47 citations85
US7094911B2Aug 22, 2006
Biphenyl and biphenyl-analogous compounds as integrin antagonists
BAYER AG0 citations52
US6589972B2Jul 8, 2003
β-phenylalanine derivatives as integrin antagonists
BAYER AG0 citations52
US6495545B1Dec 17, 2002
1,4-benzodiazepinone derivatives and their use as integrin antagonists
BAYER AG0 citations52
US6339083B1Jan 15, 2002
Multiheterocyclic pharmAceuticals
BAYER AG0 citations52
US7220824B1May 22, 2007
Integrin-mediated drug targeting
BAYER AG0 citations39
BAYER HEALTHCARE AG
3 patentsUS7338781B2Mar 4, 2008
Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
BAYER HEALTHCARE AG5 citations60
US7491550B2Feb 17, 2009
Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2)
BAYER HEALTHCARE AG0 citations50
US7465548B2Dec 16, 2008
Methods of screening for potential therapeutics for diseases associated with G-protein coupled receptor HM74a
BAYER HEALTHCARE AG0 citations47